Team finds broken 'brake' on cancer mutation machine.

Published Date: 09 Aug 2023

According to a group led by UT Southwestern Medical, loss of the SYNCRIP gene in prostate cancer tumors unleashes cellular machinery that leads to random mutations throughout the genome that increase resistance to targeted therapies.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For incarcerated people, study shows gaps exist in quality of cancer care

2.

How a California Oncologist Making $850k Spends Money

3.

The most precise research tools for the deadliest blood cancer have been developed.

4.

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

5.

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot